Inactive Instrument

Greenbrook TMS Inc. Toronto S.E.

Equities

GTMS

CA3937043097

Healthcare Facilities & Services

Greenbrook TMS Inc. Reports Earnings Results for the Full Year Ended December 31, 2021

March 30, 2022

Greenbrook TMS Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 24.75 million compared to USD 29.66 million a year ago. Basic loss per share from continuing operations was USD 1.6 compared to USD 2.32 a year ago.

Diluted loss per share from continuing operations was USD 1.6 compared to USD 2.32 a year ago.

Latest news about Greenbrook TMS Inc.

Greenbrook TMS Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08:39pm	CI
Madryn Asset Management Engages in Discussions with Greenbrook TMS	Apr. 08	CI
Greenbrook TMS Inc. Enters into the Twenty-Seventh Amendment to the Credit Agreement	Mar. 15	CI
Greenbrook TMS Inc. Appoints Andrew Crish as Chief Operating Officer	Mar. 04	CI
Greenbrook TMS Inc. Enters into the Twenty-Sixth Amendment to Credit Agreement	Mar. 01	CI
Sector Update: Health Care Stocks Advance Friday Afternoon	Feb. 23	MT
Greenbrook TMS Shares Tumble Ahead of Delisting; Trading to be Suspended Monday	Feb. 23	MT
Greenbrook TMS Inc.(OTCPK:GBNH.F) dropped from NASDAQ Composite Index	Feb. 22	CI
Greenbrook TMS Inc. Raises USD 2.5 Million in Debt Financing	Feb. 15	CI
Greenbrook TMS Inc. announced that it has received $2.538071 million in funding	Feb. 14	CI
Greenbrook TMS Inc. Raises USD 1.5 Million in Debt Financing	Feb. 06	CI
Greenbrook TMS Inc. announced that it has received $1.522843 million in funding	Feb. 05	CI
Greenbrook TMS Names Peter Willett as Finance Chief	Jan. 30	MT
Greenbrook TMS Inc. Appoints Peter Willett as Chief Financial Officer	Jan. 29	CI
Greenbrook TMS Inc. Appoints Juliana Elstad as an Independent Director and Member of Governance and Nominating Committee	Jan. 23	CI
Greenbrook TMS Inc. Raises USD 1.5 Million in Debt Financing	Jan. 19	CI
Greenbrook TMS Inc. announced that it has received $1.522843 million in funding	Jan. 18	CI
Compass Pathways, Greenbrook TMS Start Research Collaboration on Psilocybin Treatment	Jan. 05	MT
Compass Pathways plc and Greenbrook TMS Inc. Jointly Announce They Enter into Three-Year Research Collaboration Agreement to Explore Delivery Models for Investigational COMP360 Psilocybin Treatment Upon Regulatory Approval by U.S. Food and Drug Administration	Jan. 05	CI
Greenbrook TMS Obtains Additional $5.3 Million Debt Financing	Dec. 29	MT
Greenbrook TMS Inc. Raises USD 5.3 Million in Debt Financing	Dec. 28	CI
Greenbrook TMS Inc. announced that it has received $5.262952 million in funding	Dec. 27	CI
Greenbrook TMS Inc. announced that it expects to receive $4.015548 million in funding from Madryn Asset Management, LP	Dec. 14	CI
Greenbrook Tms Inc. Raises USD 2.5 Million in Debt Financing	Nov. 16	CI
Transcript : Greenbrook TMS Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09

Chart Greenbrook TMS Inc.

Duration

Period

More charts

Company Profile

Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine nasal spray) therapy in the United States for the treatment of depressive disorder (MDD) and other mental health disorders. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The Company operates a network of outpatient mental health service centers that specialize in Treatment across the United States. It offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The Company owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.

Sector

Healthcare Facilities & Services

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
AIER EYE HOSPITAL GROUP CO., LTD.	-22.63%	15.76B
BANGKOK DUSIT MEDICAL SERVICES	+3.60%	12.34B
IHH HEALTHCARE	+3.65%	11.52B
APOLLO HOSPITALS ENTERPRISE LIMITED	+10.90%	11.02B
ENCOMPASS HEALTH CORPORATION	+24.00%	8.28B
RAMSAY HEALTH CARE LIMITED	-2.03%	7.8B
MOUWASAT MEDICAL SERVICES COMPANY	+20.75%	7.2B
THE ENSIGN GROUP, INC.	+4.53%	6.67B
GLOBAL HEALTH LIMITED	+49.97%	4.64B

Hospitals, Clinics & Primary Care Services